Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s Disease

Management of Parkinson’s disease traditionally relies solely on clinical assessment. The PKG objectively measures affected persons’ movements in daily life. The present study evaluated how often PKG data changed treatment decisions in routine clinical care and to what extent the clinical assessment...

Full description

Bibliographic Details
Main Authors: Mathias Sundgren, Mattias Andréasson, Per Svenningsson, Rose-Marie Noori, Anders Johansson
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/11/6/519
_version_ 1797531224657362944
author Mathias Sundgren
Mattias Andréasson
Per Svenningsson
Rose-Marie Noori
Anders Johansson
author_facet Mathias Sundgren
Mattias Andréasson
Per Svenningsson
Rose-Marie Noori
Anders Johansson
author_sort Mathias Sundgren
collection DOAJ
description Management of Parkinson’s disease traditionally relies solely on clinical assessment. The PKG objectively measures affected persons’ movements in daily life. The present study evaluated how often PKG data changed treatment decisions in routine clinical care and to what extent the clinical assessment and the PKG interpretation differed. PKG recordings were performed before routine visits. The neurologist first made a clinical assessment without reviewing the PKG. Signs and symptoms were recorded, and a treatment plan was documented. Afterward, the PKG was evaluated. Then, the neurologist decided whether to change the initial treatment plan or not. PKG review resulted in a change in the initial treatment plan in 21 of 66 participants (31.8%). The clinical assessment and the PKG review differed frequently, mainly regarding individual overall presence of motor problems (67%), profile of bradykinesia/wearing off (79%), dyskinesia (35%) and sleep (55%). PKG improved the dialogue with the participant in 88% of cases. PKG and clinical variables were stable when they were repeated after 3–6 months. In conclusion, PKG information changes treatment decisions in nearly a third of people with Parkinson’s disease in routine care. Standard clinical assessment and PKG evaluation are often non-identical. Objective measurements in people living with Parkinson’s disease can add therapeutically relevant information.
first_indexed 2024-03-10T10:40:48Z
format Article
id doaj.art-30908929ad42405fbee195ce8ec49ed2
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-10T10:40:48Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-30908929ad42405fbee195ce8ec49ed22023-11-21T22:55:09ZengMDPI AGJournal of Personalized Medicine2075-44262021-06-0111651910.3390/jpm11060519Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s DiseaseMathias Sundgren0Mattias Andréasson1Per Svenningsson2Rose-Marie Noori3Anders Johansson4Department of Neurology, Karolinska University Hospital, 171 64 Stockholm, SwedenDepartment of Neurology, Karolinska University Hospital, 171 64 Stockholm, SwedenDepartment of Neurology, Karolinska University Hospital, 171 64 Stockholm, SwedenDepartment of Neurology, Karolinska University Hospital, 171 64 Stockholm, SwedenDepartment of Neurology, Karolinska University Hospital, 171 64 Stockholm, SwedenManagement of Parkinson’s disease traditionally relies solely on clinical assessment. The PKG objectively measures affected persons’ movements in daily life. The present study evaluated how often PKG data changed treatment decisions in routine clinical care and to what extent the clinical assessment and the PKG interpretation differed. PKG recordings were performed before routine visits. The neurologist first made a clinical assessment without reviewing the PKG. Signs and symptoms were recorded, and a treatment plan was documented. Afterward, the PKG was evaluated. Then, the neurologist decided whether to change the initial treatment plan or not. PKG review resulted in a change in the initial treatment plan in 21 of 66 participants (31.8%). The clinical assessment and the PKG review differed frequently, mainly regarding individual overall presence of motor problems (67%), profile of bradykinesia/wearing off (79%), dyskinesia (35%) and sleep (55%). PKG improved the dialogue with the participant in 88% of cases. PKG and clinical variables were stable when they were repeated after 3–6 months. In conclusion, PKG information changes treatment decisions in nearly a third of people with Parkinson’s disease in routine care. Standard clinical assessment and PKG evaluation are often non-identical. Objective measurements in people living with Parkinson’s disease can add therapeutically relevant information.https://www.mdpi.com/2075-4426/11/6/519Parkinson’s diseaseobjective measurementPKGdevicetreatment
spellingShingle Mathias Sundgren
Mattias Andréasson
Per Svenningsson
Rose-Marie Noori
Anders Johansson
Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s Disease
Journal of Personalized Medicine
Parkinson’s disease
objective measurement
PKG
device
treatment
title Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s Disease
title_full Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s Disease
title_fullStr Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s Disease
title_full_unstemmed Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s Disease
title_short Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s Disease
title_sort does information from the parkinson kinetigraph™ pkg influence the neurologist s treatment decisions an observational study in routine clinical care of people with parkinson s disease
topic Parkinson’s disease
objective measurement
PKG
device
treatment
url https://www.mdpi.com/2075-4426/11/6/519
work_keys_str_mv AT mathiassundgren doesinformationfromtheparkinsonkinetigraphpkginfluencetheneurologiststreatmentdecisionsanobservationalstudyinroutineclinicalcareofpeoplewithparkinsonsdisease
AT mattiasandreasson doesinformationfromtheparkinsonkinetigraphpkginfluencetheneurologiststreatmentdecisionsanobservationalstudyinroutineclinicalcareofpeoplewithparkinsonsdisease
AT persvenningsson doesinformationfromtheparkinsonkinetigraphpkginfluencetheneurologiststreatmentdecisionsanobservationalstudyinroutineclinicalcareofpeoplewithparkinsonsdisease
AT rosemarienoori doesinformationfromtheparkinsonkinetigraphpkginfluencetheneurologiststreatmentdecisionsanobservationalstudyinroutineclinicalcareofpeoplewithparkinsonsdisease
AT andersjohansson doesinformationfromtheparkinsonkinetigraphpkginfluencetheneurologiststreatmentdecisionsanobservationalstudyinroutineclinicalcareofpeoplewithparkinsonsdisease